Best Practices




This article explores the literature on the overall risk of malignancy in AD and the risk associated with use of common topical and immunosuppressive medications, as well as newer therapeutic options.

Case Reports

A 22-year-old female equestrian with a history of atopic dermatitis presented with mild to moderate pruritic, erythematous patches on her face (Figure 1), upper back, and fingers (Figure 2). Prior to this initial office visit, treatment with a “ringworm ointment” was unsuccessful.